Corrigendum to “Berberine associated photodynamic therapy promotes autophagy and apoptosis via ROS generation in renal carcinoma cells” [Biomed. Pharmacother., v.123 (2020) 109794] - 14/03/20
Doi : 10.1016/j.biopha.2020.110038
Tairine Zara Lopes a, Fabio Rogério de Moraes b, c, Antonio Claudio Tedesco d, Raghuvir Krishnaswamy Arni b, c, Paula Rahal a, Marilia Freitas Calmon a, ⁎ 
a Laboratory of Genomics Studies, São Paulo State University, São José do Rio Preto, São Paulo, Brazil
b Physics Department, São Paulo State University, São José do Rio Preto, São Paulo, Brazil
c Multiuser Center for Biomolecular Innovation, São Paulo State University, São José do Rio Preto, São Paulo, Brazil
d Department of Chemistry, Center of Nanotechnology and Tissue Engineering-Photobiology and Photomedicine Research Group, Faculty of Philosophy, Sciences and Letters of Ribeirao Preto, University of São Paulo, Ribeirao Preto, SP, Brazil
⁎Corresponding author at: Department of Biology, Instituto de Biociências, Letras e Ciências Exatas – IBILCE/UNESP, Cristóvão Colombo, 2265, 15054-000, São José do Rio Preto, SP, Brazil.Department of BiologyInstituto de BiociênciasLetras e Ciências Exatas – IBILCE/UNESPCristóvão Colombo, 2265São José do Rio PretoSP15054-000Brazil
Le texte complet de cet article est disponible en PDF.
© 2020
The Author(s). Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 125
Article 110038- mai 2020 Retour au numéro
Article précédent
- Corrigendum to “Folate inhibits miR-27a-3p expression during cervical carcinoma progression and oncogenic activity in human cervical cancer cells” [Biomed. Pharmacother. 122 (2020) 109654]
- Zhe Wang, Wenhao Wang, Weihong Zhao, Zhilian Wang, Jing Yang, Wei Wang, Peng Teng, Xiaoqiang Su, Dongyan Li, Xi Zhang, Hui Wang, Min Hao
- Retraction notice to “NY-SAR-35 is involved in apoptosis, cell migration, invasion and epithelial to mesenchymal transition in glioma” [Biomed. Pharmacother. 97 (2018) 1632–1638]
- Guangyong Wu, Wei Wang, Yu Liu, Kai Zhuang, Tao Cai, Zhi Fei Wang, Liang Yang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?